Prescribing quality indicators of type 2 diabetes mellitus ambulatory care

Quality & Safety in Health Care
Liana MartirosyanFlora M Haaijer-Ruskamp

Abstract

Existing performance indicators for assessing quality of care in type 2 diabetes mellitus (T2DM) focus mostly on registration of measurements and clinical outcomes, and not on quality of prescribing. To develop a set of valid prescribing quality indicators (PQI) for internal use in T2DM, and assess the operational validity of the PQI using electronic medical records. Potential PQI for hypertension, hyperglycaemia, dyslipidaemia and antiplatelet treatment in T2DM were based on clinical guidelines, and assessed on face and content validity in an expert panel followed by a panel of GPs and diabetologists. Analysis of ratings was performed using the RAND/UCLA Appropriateness Method. The operational validity of selected indicators was assessed in a dataset of 3214 T2DM patients registered with 70 GPs. Out of 31 potential prescribing indicators, the expert panel considered 18 indicators as sufficiently valid, of which 14 indicators remained valid after assessment by the panel of GPs and diabetologists. Of these 14 indicators, one could not be calculated because of an absence of eligible patients. For the remaining indicators, outcomes varied from 10% for timely prescribing of insulin to 96% for prescribing of any antihyperglycemic me...Continue Reading

Citations

Jul 27, 2011·Family Practice·Liset van DijkDinny H de Bakker
May 28, 2010·BMC Health Services Research·Liana MartirosyanPetra Denig
Jul 10, 2012·BMC Health Services Research·Liana MartirosyanJozé Braspenning
Mar 23, 2012·Implementation Science : IS·Thomas KötterMartin Scherer
Mar 15, 2016·Diabetes Research and Clinical Practice·Kerry Wilbur, Abdulla O Al Hammaq
Oct 18, 2011·Pharmacoepidemiology and Drug Safety·Liana MartirosyanPetra Denig
Apr 25, 2016·International Journal of Clinical Pharmacy·Martina TeichertMichel Wensing
Sep 20, 2016·International Journal of Clinical Practice·Kirsten P J SmitsPetra Denig
Oct 25, 2016·The International Journal of Pharmacy Practice·Lisa G PontMieke L van Driel
Dec 17, 2016·International Journal of Clinical Practice·Kirsten P J SmitsPetra Denig
Mar 10, 2017·Journal of Evidence-based Medicine·Jie SongDan Liu
May 4, 2011·Medical Care Research and Review : MCRR·Grigory SidorenkovPetra Denig
Jan 18, 2018·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Geetha MukerjiJeannette Goguen
Jul 18, 2018·BMJ Open·Kenji FujitaTimothy F Chen

Related Concepts

Urgent Care
Diabetes Mellitus, Non-Insulin-Dependent
Hypoglycemic Effect
Outcomes Research
Best Practices
Ambulatory Care Services
Diabetes Mellitus, Non-Insulin-Dependent
General Practitioners
Glycosylated hemoglobin A
Hyperglycemia

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Journal of the American Geriatrics Society
Lillian C MinConstance H Fung
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
H S HermanidesS E Geerlings
© 2021 Meta ULC. All rights reserved